A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of <i>Weizmannia coagulans</i> BC99 in the treatment of chronic constipation in adults.

While changes in the Bristol scores from baseline to week 4 within the placebo group did not reach statistical significance ( p > 0.05), the BC99 group demonstrated significant improvements in stool form by the end of the 4-week treatment period ( p < 0.05), as depicted in Table 4 .

also in 111,027 other papers